MEI Pharma: MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum

(marketscreener.com) MEI Pharma, Inc. , a clinical-stage pharmaceutical company evaluating novel drug candidates to address known resistance mechanisms to standard-of-care cancer therapies, today announced that David Urso, president and chief executive officer of MEI Pharma, will participate in a fireside chat at the Stifel 2024 Virtual Targeted Oncology Forum on...https://www.marketscreener.com/quote/stock/MEI-PHARMA-INC-12212540/news/MEI-Pharma-to-Present-at-the-Stifel-2024-Virtual-Targeted-Oncology-Forum-46404812/?utm_medium=RSS&utm_content=20240410